Nektar(NKTR) - 2024 Q3 - Earnings Call Transcript

Nektar Therapeutics (NASDAQ:NKTR) Q3 2024 Earnings Conference Call November 7, 2024 5:00 PM ET Company Participants Vivian Wu - Associate Director, Investor Relations and Corporate Affairs Howard Robin - President and Chief Executive Officer Jonathan Zalevsky - Chief Research and Development Officer Mary Tagliaferri - Chief Medical Officer Sandra Gardiner - Chief Financial Officer Conference Call Participants Yasmeen Rahimi - Piper Sandler Julian Harrison - BTIG Jessica Fye - JPMorgan Andy Hsieh - William B ...